LMAT: the cash flow

MyFinsight

For the quarter ending 2026-03-31, LMAT had -$1,393K decrease in cash & cash equivalents over the period. $12,310K in free cash flow.

Cash Flow Overview

Change in Cash
-$1,393K
Free Cash flow
$12,310K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales of short-ter...
Proceeds from stock option exerc...
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Purchases of short-term marketab...
Cost of sales
Selling expense
Others

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net sales	66,551	64,453	185,149	-
Cost of sales	18,155	18,263	52,800	-
Gross profit	48,396	46,190	132,349	-
Selling expense	12,800	12,162	37,272	-
Marketing expense	1,715	1,272	3,758	-
Administrative expense	7,963	6,975	21,268	-
Finance expense	3,184	2,718	8,322	-
Management information systems expense	899	698	2,043	-
Research and development expense	1,423	1,069	2,970	-
Process engineering expense	1,002	802	1,828	-
Regulatory and clinical expense	1,635	1,662	5,808	-
Restructuring expense	-	0	-	-
Other (income) expense, net	-2,096	-3,250	-6,928	-
Net income	15,679	15,582	17,362	24,790
Depreciation and amortization	2,623	2,605	2,613	5,200
Stock-based compensation	2,092	2,096	1,740	3,990
Amortization of issuance costs on convertible senior notes	222	220	653	-
Non-cash investment income	102	-	-	-
Provision for inventory write-downs	761	768	863	1,030
Provision (benefit) for deferred income taxes	-	2,312	-	-
Loss on divestitures	-	0	-	-
Provision for credit losses	0	362	118	337
Fair value adjustments to contingent consideration obligations	-	-	0	0
Unrealized loss on equity investments	-	-535	-	-
Foreign currency transaction effect on income	-71	97	-200	279
Accounts receivable	2,481	1,544	-3,896	5,299
Inventory and other deferred costs	1,392	418	6,805	-
Prepaid expenses and other assets	-1,038	-787	37	-1,676
Non-cash interest expense and end of term accretion expense	-	-	-	2,589
Accounts payable and other liabilities	-2,340	-1,129	6,577	-1,250
Inventory and other deferred costs	-	-	-	3,454
Accrued interest	-1,078	1,078	719	-
Net cash provided by operating activities	15,093	23,157	28,764	29,330
Purchases of short-term marketable securities	150,866	598,314	25,166	17,849
Purchases of property and equipment	2,783	1,777	2,281	2,725
Payments related to acquisitions, net of cash acquired	45	1,804	0	95
Proceeds from sales of short-term marketable securities	140,573	585,070	-	-
Net cash used in investing activities	-13,121	-16,825	-27,447	-20,669
Proceeds from stock option exercises	2,952	2,166	1,585	3,072
Proceeds from issuance of convertible senior notes, net of issuance costs paid of 3,234	-	0	-	-
Deferred payments for acquisitions	0	0	0	1,433
Costs paid related to issuance of convertible senior notes-Convertible Senior Notes	-	0	-	-
Payment of withholding taxes in connection with net settlement of equity awards	460	1,216	0	605
Common stock cash dividend paid	5,711	4,537	4,535	9,037
Net cash used in financing activities	-3,219	-3,587	-2,950	-8,003
Effect of exchange rate changes on cash and cash equivalents	-146	5	-50	909
Net increase (decrease) in cash and cash equivalents	-1,393	2,750	-1,683	1,567
Cash and cash equivalents at beginning of period	28,244	25,494	2,589	-
Cash and cash equivalents at end of period	26,851	28,244	25,494	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Cash Flow Overview

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Cash Flow Overview

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow